
Home » Prescription Drugs 14 » SELGIN Eldepryl
Selegiline is used to help control the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement muscle control and balance) in people who are taking levodopa and carbidopa combination (Sinemet). Selegiline may help people with Parkinson's disease by decreasing the dose of levodopa/carbidopa needed to control symptoms stopping the effects of levodopa/carbidopa from wearing off between doses and increasing the length of time that levodopa/carbidopa will continue to control symptoms. Selegiline is in a group of medications called monoamine oxidase type B (MAO-B) inhibitors. It works by increasing the amount of dopamine (a natural substance that is needed to control movement) in the brain.Selegiline comes as a capsule and an orally disintegrating (dissolving) tablet to take by mouth. The capsule is usually taken twice a day with breakfast and with lunch. The orally disintegrating tablet is usually taken once a day before breakfast without food water or other liquids. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take selegiline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. If you take too much selegiline you may experience a sudden and dangerous increase in your blood pressure.
Buy SELGIN Eldepryl and other Prescription Drugs 14 products online
at Medstore.
555 Buy Online at Medstore - Click Here!

About SELGIN Eldepryl:
Product Type: Prescription Drugs 14
SELGIN ( Eldepryl Zelapar Generic Selegiline )
SELGIN (Eldepryl Zelapar Generic Selegiline)
Eldepryl Zelapar Generic Selegiline
5mg Tabs 100 Tablets
Eldepryl Zelapar Generic Selegiline SELGIN

View more
Prescription Drugs 14
Previous Product Next Product
Without A Prescription:
Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests.
The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections.
Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed.
But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.


|